Skip to content
Newsroom
Careers
Contact
(732) 640-0058
Search the website
Why Ascendia?
What We Do
Leadership
History
Technologies
LipidSol
EmulSol
AmorSol
NanoSol
Controlled Release
Services
Streamlined Development
Pre-Formulation
Formulation Development
Analytical Services
Small-Scale Formulations
ICH Stability Studies
Manufacturing
GMP and cGMP
Applied Clinical Trial Materials
Our Facility & Equipment
Partner with Ascendia
Search the website
Why Ascendia?
What We Do
Leadership
History
Technologies
LipidSol
EmulSol
AmorSol
NanoSol
Controlled Release
Services
Streamlined Development
Pre-Formulation
Formulation Development
Analytical Services
Small-Scale Formulations
ICH Stability Studies
Manufacturing
GMP and cGMP
Applied Clinical Trial Materials
Our Facility & Equipment
Partner with Ascendia
Newsroom
Careers
Contact
(732) 640-0058
Search the website
Newsroom
First
Prev
1
2
Next
Last
Meet Ascendia Pharmaceutical Solutions at CPhI Worldwide 2025 in Frankfurt
Oct 1, 2025 2:02:42 PM
Stability Chambers: Testing, Equipment & Uses
Mar 6, 2023 12:00:00 AM
Gene Therapy CDMO: Choosing the Right One
Feb 27, 2023 12:00:00 AM
Pre-Filled Syringes: Aseptic Filling and Manufacturing
Jan 26, 2023 12:00:00 AM
Ascendia to Attend JPM Week, Biotech Showcase in San Francisco
Dec 22, 2022 12:00:00 AM
Ascendia Pharmaceuticals Expands Senior Staff as Part of Continued Growth
Oct 4, 2022 12:00:00 AM
cGMP Manufacturing in the Pharmaceutical Industry
Sep 1, 2022 12:00:00 AM
Long-Acting Injectables (LAIs): Benefits & Drug Development
Sep 1, 2022 12:00:00 AM
How to Select a CDMO Partner for Early Stage Drug Development
Mar 27, 2019 12:00:00 AM
How Nano-formulations Aid in Advancing Insoluble Drug Candidates
Mar 26, 2019 12:00:00 AM
ASCENDIA PHARMACEUTICALS ANNOUNCES A NEW PATENT ON ITS ASD-002 PROGRAM
Jan 6, 2017 12:00:00 AM
Recent Innovations in Pharmaceutical Hot Melt Extrusion
Sep 19, 2015 12:00:00 AM